Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 15/07/2011
PIL Neurontin Capsules and Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/03/2010 and displayed until 15/07/2011
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 09/03/2010 and displayed until 22/03/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 28/01/2009 and displayed until 09/03/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 16/12/2008 and displayed until 28/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/08/2008 and displayed until 16/12/2008
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to side-effects
  • Change due to user-testing of patient information
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 23/10/2007 and displayed until 01/08/2008
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 08/12/2006 and displayed until 23/10/2007
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 23/11/2005 and displayed until 08/12/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   gabapentin